含Zr聚乙炔基苯胺树脂的制备

以四氯化锆、苯乙炔和间乙炔基苯胺(APA)为原料,通过先驱体合成法制备新型含锆有机先驱体树脂——含Zr聚乙炔基苯胺树脂(ZAPA)。通过FT-IR表征了其结构,利用DSC及FT-IR研究了其固化反应,通过TG研究了其固化物的耐热性能,采用XRD和EDS研究了其固化物的烧结性能。结果表明：ZAPA树脂可以发生固化交联反应,其固化物相对于APA的固化物具有更好的耐热性能,在N2气氛下,ZAPA树脂固化物失重5%的温度为445 °C,1 000 °C下的质量残余率为43.7%;在空气气氛中,1 000 °C下烧结5 h后,可形成ZrO2晶体。     

改性硅炔树脂及其复合材料的耐热性能

通过格氏试剂反应制得了改性硅炔杂化树脂（GMD）。采用DSC、TGA等分析方法研究了GMD的固化反应及耐热性能。结果表明：GMD固化物在氮气气氛下质量损失5%时的温度(Td5)为631 °C,1 000 °C时的质量残留率为59%。所制备的玻璃纤维增强复合材料在常温下的弯曲强度为320 MPa,在240 °C的弯曲强度保留率高达90%,空气条件下经500 °C处理7 min后,质量保留率仍达到99.7%。该复合材料的玻璃化温度大于400 °C,具有优异的耐热性能、力学性能及介电性能。     

聚(间乙炔基-甲基氢苯基硅烷)树脂的合成及其耐热性能

以二氯甲基硅烷和间二乙炔基苯为原料,通过有机镁格氏试剂与卤代硅烷的缩合反应,合成得到了一种新结构的聚(间乙炔基 甲基氢苯基硅烷)树脂（PCS）。采用FT-IR、1H-NMR、13C-NMR和GPC对树脂的结构进行了表征,采用DSC和TGA对树脂的固化反应和热稳定性能进行了研究。结果表明：PCS树脂在 160 °C及 240 °C处有固化反应放热峰;其固化产物具有优异的耐热及耐热氧化性能,在氮气与空气氛围下质量损失5%的温度（Td5）分别为644、595 °C,而1 000 °C的质量保留率分别为 89.0%、57.9%。     

双（N-间乙炔基苯基邻苯二甲酰亚胺）醚改性苯乙炔基硅氧硼烷

用双（N-间乙炔基苯基邻苯二甲酰亚胺）醚（DAIE）改性苯乙炔基硅氧硼烷（PESB）制得复合材料基体树脂(PESBDAIE)。通过FT-IR、DSC和TG研究了PESBDAIE的固化反应及耐热性。将PESBDAIE与纤维复合制得复合材料,研究了该材料的耐热性、弯曲强度及断面形貌。研究结果表明,固化物在氮气气氛下质量损失5%时的温度(T5%)为576 °C,空气气氛下T5%为507 °C。复合材料在500 °C下放置10 min后质量保留率为97.0%,弯曲强度为176 MPa。     

硅炔杂化树脂改性有机硅树脂及其复合材料的性能

用一种硅炔杂化树脂聚（甲基硅烷-二乙炔基苯）（PSP）改性有机硅树脂（HS）,通过FT-IR和TGA研究了树脂体系的固化反应及耐热性,并对制备的复合材料进行力学性能、耐热性能和介电性能研究。结果表明：当HS与PSP的质量比为5∶5时综合性能最优,树脂体系在氮气氛围下质量损失5％时的温度(Td5)为691 °C,1 000 °C时质量保留率为88%;HS-PSP树脂短切玻纤复合材料冲击强度为21 kJ/m2,弯曲强度为65 MPa,200 °C时的弯曲强度高温保留率为78%,介电常数为4.6,介电损耗因数为7.9×10-3,体积电阻为6.7×1013 Ω。改性后的复合材料具有优异的力学、耐热和介电性能。     

聚甲基二间苯二乙炔基硅烷改性二氧化双环戊二烯环氧树脂及其复合材料的性能

用聚甲基二间苯二乙炔基硅烷树脂(PSA）改性二氧化双环戊二烯（R122环氧树脂）得到R122/PSA树脂体系,并以该树脂为基体制备了玻璃纤维复合材料。通过FTIR、DSC和TGA研究了R122/PSA树脂的固化反应及其耐热性能,同时研究了R122/PSA基复合材料的力学性能、耐热性能、介电性能和耐水性能。结果表明：改性树脂在高温下保持了良好的耐热性能,mPSA/mR122=02的固化物在800 °C下质量保留率比纯R122树脂的提高了30%。所制备的复合材料常温下弯曲强度达到735 MPa,220 °C下的弯曲强度达到4184 MPa,不仅保留了良好的力学性能,而且耐热性能得到了很好的提升,同时其浸泡96 h后的吸水率仅为065%,耐水性能优异。     

紫外光固化脂环族环氧丙烯酸酯涂料的制备及性能

通过丙烯酸（AA）与脂环族环氧树脂的开环反应合成了可紫外光（UV）固化的脂环族环氧丙烯酸酯树脂（CEA）。采用红外光谱（FT-IR）对树脂结构进行了表征,研究了反应温度、反应时间对产率的影响。用活性稀释剂与CEA制备了涂料预聚物,用转板黏度计测定了预聚物的黏度,采用差示扫描量热（DSC）仪、综合热分析仪和铅笔硬度计对树脂固化膜进行了分析。结果表明：当丙烯酸与环氧基团摩尔比为1/3,120 °C下反应25.8 h时,反应转化率可达96.58%。CEA固化膜的玻璃化转变温度为64 °C,初始分解温度为314 °C,活性稀释剂的加入增强了固化膜的耐热性,固化膜铅笔硬度可达6 H。     

三(3-乙炔基苯胺)-苯基硅烷改性含硅芳炔树脂的性能

以苯基三氯硅烷、3-氨基苯乙炔为原料,通过胺解反应合成了三（3-乙炔基苯胺）苯基硅烷（SZTA）,并通过傅里叶变换红外光谱（FT-IR）和核磁共振氢谱（¹H-NMR）表征了其结构。随后通过熔融共混的方法制备了不同配比的改性含硅芳炔树脂（PSA/SZTA）,借助黏度计、流变仪、差示扫描量热仪（DSC）、电子万能试验机、热重分析仪（TG）等考察了改性树脂的工艺性能、固化特性、弯曲性能、热稳定性能和热解动力学等。结果显示,引入SZTA后,改性PSA树脂的黏度降低62%;改性PSA树脂固化物的弯曲强度最高达到34.6 MPa,比未改性的PSA树脂提高了约54%;且改性树脂固化物在N₂中的5%热失重温度（T_d5）均高于500 ℃,保持了良好的耐热性能;PSA/SZTA-20固化物的热解表观活化能（E_a）的平均值为249 kJ/mol。     

聚苯乙炔基苯基硅氧硼烷树脂及其复合材料的性能

将双(N-间乙炔基苯基邻苯二甲酰亚胺)醚(DAIE)和双酚A型氰酸酯(CE)分别加到聚苯乙炔基苯基硅氧硼烷(PSOB)和三苯乙炔基苯基硅烷（PTPES）混合体系中进行改性,制得两种纤维增强复合材料PSOB-PTPES-DAIE和PSOB-PTPES-CE。研究了固化后树脂的热稳定性能、力学性能、介电性能和耐水性能。结果表明：两种改性树脂高温下均保持了良好的耐热性能,在氮气中质量损失5%时的温度(T5%)最高可达534 °C,800 °C下质量保留率最高可达62.9%。所制备的两种复合材料体系常温下弯曲强度可达250 MPa以上,240 °C下的弯曲强度最高可达202 MPa。饱和吸水率最低可达1.4%,耐水性能优良。不同处理条件下的复合材料介电常数与介电损耗角正切值变化较小,介电性能良好。     

新型含锆硅炔陶瓷材料的制备与性能

以甲基氢二氯硅烷（MeHSiCl₂）、正丁基锂（n-BuLi）、三氯乙烯（HClCC=Cl₂）与四氢铝锂（LiAlH₄）为原料制备主链含H-Si-C≡C的硅炔聚合物（HS）,将硅源与锆源（HG）进行共混,制备了一种新型复合陶瓷前驱体（GP）。采用傅里叶变换红外光谱（FT-IR）和核磁共振（NMR）对HS结构进行表征;利用FT-IR、差示扫描量热分析（DSC）与热失重分析（TGA）分别探讨GP固化行为及其耐热性能;通过X射线衍射（XRD）与激光显微拉曼光谱（Raman）等研究GP的陶瓷化性能。结果表明,GP具有优良的热稳定性能与陶瓷化性能,在1 600℃氩气气氛下保温3 h可得到ZrC-ZrO₂-SiC复相陶瓷,质量保留率达到75.64%。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…